Skip to content

Advertisement

Open Peer Review Reports for: A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
29 Aug 2016 Submitted Original manuscript
10 Jan 2017 Reviewed Reviewer Report - Nick Woods
28 Feb 2017 Reviewed Reviewer Report - Komaraiah Palle
11 May 2017 Author responded Author comments - Zhor Senhaji Mouhri
Resubmission - Version 2
11 May 2017 Submitted Manuscript version 2
24 May 2017 Reviewed Reviewer Report - Nick Woods
10 Jul 2017 Author responded Author comments - Zhor Senhaji Mouhri
Resubmission - Version 3
10 Jul 2017 Submitted Manuscript version 3
22 Jul 2017 Author responded Author comments - Zhor Senhaji Mouhri
Resubmission - Version 4
22 Jul 2017 Submitted Manuscript version 4
Publishing
24 Jul 2017 Editorially accepted
11 Aug 2017 Article published 10.1186/s12885-017-3504-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement